These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 2185770)
1. [In whom, when and how should increased cholesterol values be treated?]. Greten H Arzneimittelforschung; 1990 Mar; 40(3A):381-3. PubMed ID: 2185770 [TBL] [Abstract][Full Text] [Related]
2. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis]. Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811 [TBL] [Abstract][Full Text] [Related]
3. Prevention of coronary heart disease through cholesterol reduction. Grundy SM Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652 [TBL] [Abstract][Full Text] [Related]
4. [Statins in primary prevention of coronary heart disease]. Paulweber B Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004 [TBL] [Abstract][Full Text] [Related]
5. [Lipid-lowering therapy in the prevention of coronary heart disease]. Keller U Schweiz Rundsch Med Prax; 1990 Sep; 79(39):1120-4. PubMed ID: 2218247 [TBL] [Abstract][Full Text] [Related]
6. The pharmacoeconomic benefits of cholesterol reduction. Gonzalez ER Am J Manag Care; 1998 Feb; 4(2):223-30. PubMed ID: 10178493 [TBL] [Abstract][Full Text] [Related]
7. [Modifying increased plasma cholesterol levels in secondary prevention of coronary heart disease]. Jost S; Lichtlen PR Z Kardiol; 1995 Aug; 84(8):577-95. PubMed ID: 7571764 [TBL] [Abstract][Full Text] [Related]
8. [The role of cholesterol-lowering drugs in prevention of coronary heart disease]. Skałuba Z; Undas R Przegl Lek; 1998; 55(7-8):382-7. PubMed ID: 10021881 [TBL] [Abstract][Full Text] [Related]
9. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III. Talbert RL Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701 [TBL] [Abstract][Full Text] [Related]
10. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease. Marchioli R; Marfisi RM; Carinci F; Tognoni G Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010 [TBL] [Abstract][Full Text] [Related]
11. Primary prevention of CHD: nine ways to reduce risk. Havranek EP Am Fam Physician; 1999 Mar; 59(6):1455-63, 1466. PubMed ID: 10193589 [TBL] [Abstract][Full Text] [Related]
12. [Hypercholesterolemia in patients with hypertension and diabetes mellitus. The need for cholesterol control in the prevention of ischemic heart disease]. Heyden S Wien Med Wochenschr; 1986 Sep; 136(17):437-42. PubMed ID: 3798928 [TBL] [Abstract][Full Text] [Related]
13. [Decisions regarding cholesterol-lowering therapy in the elderly: the experience in a lipid clinic and a review of the literature]. Garrido Sanjuán JA; Pía Iglesias G; González Moraleja J; Sesma P An Med Interna; 1998 Jun; 15(6):305-10. PubMed ID: 9656510 [TBL] [Abstract][Full Text] [Related]
14. Lipid levels. Applying the second National Cholesterol Education Program report to geriatric medicine. Mormando RM Geriatrics; 2000 Aug; 55(8):48-53; quiz 54. PubMed ID: 10953686 [TBL] [Abstract][Full Text] [Related]
15. Cholesterol reduction therapy: a double-edged knife. Ong HT Med J Malaysia; 1993 Jun; 48(2):107-12. PubMed ID: 8350783 [TBL] [Abstract][Full Text] [Related]
20. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]